Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172623 | SCV000054905 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000172623 | SCV000237708 | likely benign | not provided | 2021-04-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082027 | SCV000643850 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293122 | SCV001434112 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Ambry Genetics | RCV002354443 | SCV002654934 | likely benign | Cardiovascular phenotype | 2020-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000172623 | SCV003824842 | uncertain significance | not provided | 2022-11-08 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000172623 | SCV001920583 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172623 | SCV001966299 | uncertain significance | not provided | no assertion criteria provided | clinical testing |